IP Library Granted Patent US 9,771,592
Granted Patent B2
US 9,771,592 · App. 14/163,370 · Granted Sep 26, 2017

Methods and compositions for treating or preventing pruritis

Inventors: Xinzhong Dong (Clarksville, MD); Qin Liu (Baltimore, MD); David J. Anderson (Altadena, CA)
Assignees: The Johns Hopkins University; California Institute of Technology
C12N15/1138A61K31/439A61K31/46A61K31/56A61K31/7088A61K31/713A61K45/06C07K14/705G01N33/5023G01N33/5041
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,771,592
App. No.
14/163,370
Granted
Sep 26, 2017
Kind
B2
Abstract

The invention features therapeutic compositions comprising agents useful for the treatment or prevention of pruritis, and methods useful for identifying such agents.

Claims (11)

1. A method of treating pruritis in a subject in need thereof, the method comprising administering to the subject an effective amount of a compound of formula I, wherein formula I is represented as follows:

represents an optional double bond;

when is a single bond, X is selected from the group consisting of: —O—, —S— and —CH 2 S

when is a double bond, X is selected from the group consisting of: ═N— and ═CH—;

Y is selected from the group consisting of: H, —OH, ═0, ═S and halo;

Z is selected from the group consisting of: a bond, —O—, —S—, —NH— and —CH2-;

R 1 , R 2 and R 3 are independently selected from the group consisting of: H, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, halo, cyano, nitro, trifluoromethyl, trimethylsilyl, —OR a , SR a , SOR a , Sθ2R a , —NR a R b , —NR a COR b , NR a CO 2 R b , —C0 2 R a and —CONR a R b , and any two of R 1 , R 2 or R 3 may be joined together with the phenyl atom to which they are attached to form naphthyl; and

R a and R b are independently selected from the group consisting of: H, C 1-6 alkyl, phenyl and trifluoromethyl.

2. The method of claim 1 , wherein the compound of formula I is administered in combination with an anti-histamine or a corticosteroid.

3. The method of claim 2 , wherein the subject has a condition selected from the group consisting of a dermatologic disorder, exposure to a surface irritant, chronic renal disease, liver disease, bacterial or viral infection, a parasitic infestation, opioid administration, multiple sclerosis, hyperparathyroidism; diabetes mellitus, iron deficiency anemia, allergic reactions to a drug, an adverse side effect associated with a vasoactive drug, CNS active agent or chloroquine, Hodgkin's disease, polycythemia rubra vera, leukemia, mycosis fungoides, Sézary syndrome, visceral neoplasia, carcinoid, multiple myeloma, and pregnancy.

4. The method of claim 1 , wherein the subject has chloroquine-induced itch.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 27, 2017
From: CALIFORNIA INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043112/0992 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2016
From: DONG, XINZHONG; LIU, QIN
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 038391/0747 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2016
From: ANDERSON, DAVID J.
To: CALIFORNIA INSTITUTE OF TECHNOLOGY
Reel/Frame 038391/0761 →
Continuity (3)
Division 13132268
Provisional Application 61119008 · Dec 1, 2008
Related Publication 20140303231A1 · Oct 9, 2014